Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Wild

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Investigative Ophthalmology & Visual Science|October 24, 2009
Electrophysiological evidence of early functional damage in glaucoma and ocular hypertensionRachel V North, Adrian L Jones, Neville Drasdo, et al.
Survey of Ophthalmology|June 6, 2017
The use of microperimetry in assessing visual function in age-related macular degenerationNicola K Cassels, John M Wild, Tom H Margrain, et al.
Epilepsia|November 13, 2010
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic reviewMelissa J Maguire, Karla Hemming, John M Wild, et al.
Investigative Ophthalmology & Visual Science|March 1, 2006
Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layerJohn M Wild, Catherine R Robson, Adrian L Jones, et al.
Translational Vision Science & Technology|January 11, 2020
Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in MicroperimetryNicola K Cassels, John M Wild, Tom H Margrain, et al.
Ophthalmology|February 28, 2012
The accuracy of the inferior>superior>nasal>temporal neuroretinal rim area rule for diagnosing glaucomatous optic disc damageJames E Morgan, Ioanna Bourtsoukli, Kadaba N Rajkumar, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 3, 2002
Ocular optics, electroretinography and primary open angle glaucomaNeville Drasdo, Yousef H Aldebasi, Katharine E Mortlock, et al.
CNS Drugs|August 31, 2013
Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approachJohn M Wild, David L Fone, Saleh Aljarudi, et al.
Epilepsia|July 20, 2007
Vigabatrin and epilepsy: lessons learnedJohn M Wild, Hyo-sook Ahn, Michel Baulac, et al.
Ophthalmology|March 3, 2007
The normal age-corrected and reaction time-corrected isopter derived by semi-automated kinetic perimetryReinhard Vonthein, Stephan Rauscher, Jens Paetzold, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Investigative Ophthalmology & Visual Science|October 24, 2009
Electrophysiological evidence of early functional damage in glaucoma and ocular hypertensionRachel V North, Adrian L Jones, Neville Drasdo, et al.
Survey of Ophthalmology|June 6, 2017
The use of microperimetry in assessing visual function in age-related macular degenerationNicola K Cassels, John M Wild, Tom H Margrain, et al.
Epilepsia|November 13, 2010
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic reviewMelissa J Maguire, Karla Hemming, John M Wild, et al.
Investigative Ophthalmology & Visual Science|March 1, 2006
Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layerJohn M Wild, Catherine R Robson, Adrian L Jones, et al.
Translational Vision Science & Technology|January 11, 2020
Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in MicroperimetryNicola K Cassels, John M Wild, Tom H Margrain, et al.
Ophthalmology|February 28, 2012
The accuracy of the inferior>superior>nasal>temporal neuroretinal rim area rule for diagnosing glaucomatous optic disc damageJames E Morgan, Ioanna Bourtsoukli, Kadaba N Rajkumar, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|October 3, 2002
Ocular optics, electroretinography and primary open angle glaucomaNeville Drasdo, Yousef H Aldebasi, Katharine E Mortlock, et al.
CNS Drugs|August 31, 2013
Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approachJohn M Wild, David L Fone, Saleh Aljarudi, et al.
Epilepsia|July 20, 2007
Vigabatrin and epilepsy: lessons learnedJohn M Wild, Hyo-sook Ahn, Michel Baulac, et al.
Ophthalmology|March 3, 2007
The normal age-corrected and reaction time-corrected isopter derived by semi-automated kinetic perimetryReinhard Vonthein, Stephan Rauscher, Jens Paetzold, et al.
Pageof 3